25/03/2021 09:3423 YearsÍ wÈ8YÎ *878*

¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾
Patient's Name: NIKHIL NIRANJAN JOSHI Age:23 Years Sex:Male
Refered by: C/o. SELF
Sample Collection/Received: 24/03/202120:33 Ref No: 55418-21
Report Release: 25/03/2021 09:34 Location: CLINIC
¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾¾
*Qualitative Detection of COVID-19
NOVEL CORONA VIRUS/2019 nCov/SARS-Cov-2
(ICMR REGISTRATION NUMBER:GPDCAG)

Method: RT PCR (NAT)BY ROTOR GENE Q,GERMANY/QUANT S-5 BY THERMOFISHER.

Sample: Nasopharyngeal & Oropharyngeal Swab
Test Result CT Value
N Gene: NOT DETECTED -

RDRP Gene: NOT DETECTED -

S Gene: NOT DETECTED -

RESULT: 2019-nCov Not Detected.

*Interpretation of CT Value: High Viral Load: <17 - 24,Moderate Viral Load: 25 - 31,Low/Mild Viral Load: 32 - 37
Advice: All positive cases must undergo Flu Profile for evalution of disease progression.
DISCLAIMER
Test results are highly dependent on sample type and its sensitivity , sampling techniques , biological variation and patients clinical condition.
Presence of PCR inhibitors ( can not be traced by technologist ) or viral load below LOD for the ICMR approved kits used and or mutant
genotypes may result in false negative report.
False positive results may be obtained due to background RNA enviornmental contamination in lab before it is identified
and corrective and preventive actions are taken . Results must be correlate clinically and other relavant history.
This test is not approved by FDA , NABL or CAP. The assay performance characteristics for his test are determined by GPLDC
which is used for clinical diagnosis.
Each batch of assays is run along with positive and negative control and kits approved by ICMR.
There are all changes of result variations between various perforing labs and institute due to preanalytical , analytical and
postanalytical variables. like sample collection methods , expertize , sample transport and preservation , difference in kit
sensitivity , interinstrumental variations and rest ,